Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48% [Yahoo! Finance]
Xtant Medical Holdings, Inc. (XTNT)
US:NASDAQ Investor Relations:
investor.xtantmedical.com
Company Research
Source: Yahoo! Finance
surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Revenue of $29.9 million, up 48%, compared to the prior year quarter Gross margin of 62.1%, up 50 basis points, compared to the prior year quarter Net loss of $3.9 million compared to $2.2 million in the year ago quarter Positive Adjusted EBITDA; Adjusted EBITDA of $0.5 million compared to $0.1 million in the prior year quarter Recent Business Highlights Recently launched two new amniotic membrane allografts products, SimpliGraft™ and SimpliMax™; while Cortera™ reached record sales and users for the second quarter Signed 15 new distributors in the second quarter Awarded 20 IDN contracts in the second quarter Entered into a $5.0 million private placement on August 7, 2024 Sean Browne, President and CEO of Xtant Medical, stated, "Our second quarter financial results illustrate t
Show less
Read more
Impact Snapshot
Event Time:
XTNT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XTNT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XTNT alerts
High impacting Xtant Medical Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
XTNT
News
- Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation SystemAccesswire
- Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) PlusAccesswire
- Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Xtant Medical Announces $5.0 Million Private Placement [Yahoo! Finance]Yahoo! Finance
- Xtant Medical Announces $5.0 Million Private PlacementAccesswire
XTNT
Sec Filings
- 10/16/24 - Form 4
- 9/12/24 - Form EFFECT
- 9/11/24 - Form 424B3
- XTNT's page on the SEC website